IgA plasma cell myeloma presenting as cold agglutinin-induced haemolytic transfusion reaction
Document Type
Journal Article
Publication Date
2-28-2024
Journal
BMJ case reports
Volume
17
Issue
2
DOI
10.1136/bcr-2022-251638
Keywords
Cancer; Haematology (incl blood transfusion); Malignant and Benign haematology; Medical management; Pathology
Abstract
Cold agglutinins produced in the setting of B cell neoplasms, such as lymphoplasmacytic lymphoma and plasma cell myeloma, can mediate autoimmune haemolytic anemia. Transfusion of these patients can exacerbate cold agglutinin-mediated haemolysis. Moreover, the workup for these reactions represents a diagnostic challenge due in part to false negative direct antiglobulin tests (DATs). Here, we report an anaemic patient who after a red blood cell (RBC) transfusion performed without blood warming, experienced a DAT-negative haemolytic transfusion reaction, and was later diagnosed with IgA-multiple myeloma, which showed an uncommon granular pattern by CD138 immunohistochemistry. Extensive workup excluded other diagnostic possibilities, including the presence of Donath-Landsteiner antibodies and cryoglobulins. Successful treatment with CyBorD (cyclophosphamide, bortezomib and dexamethasone) achieved complete remission, and additional RBC transfusions using warmers were completed uneventfully.
APA Citation
Mehdipour Dalivand, Maryam; Woddor, Navitha; Makuria, Addisalem; Aggarwal, Anita; and Nava, Victor Eduardo, "IgA plasma cell myeloma presenting as cold agglutinin-induced haemolytic transfusion reaction" (2024). GW Authored Works. Paper 4295.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/4295
Department
School of Medicine and Health Sciences Resident Works